Advertisement

Topics

Researchers develop new test to target prostate cancer treatment

08:02 EDT 19 Jun 2017 | PharmaTimes

UK-based scientists have developed a new three-in-one blood test able to identify the patients with advanced prostate cancer most likely to benefit from PARP inhibitors, with the potential to ‘transform’ treatment of the disease.

Original Article: Researchers develop new test to target prostate cancer treatment

NEXT ARTICLE

More From BioPortfolio on "Researchers develop new test to target prostate cancer treatment"

Advertisement
Quick Search
Advertisement
Advertisement